both

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjgrens disease

Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global phase III trials to…

9 months ago

GENESIS MAGMA RACING PREPARES FOR 24 HOURS OF LE MANS EXPERIENCE BOTH ON AND OFFTRACK

Genesis Magma Racing will have a presence at the 24 Hours of Le Mans, both on track and in the…

11 months ago